Crescent Capital BDC (CCAP) Expected to Announce Earnings on Wednesday

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) is expected to post its Q1 2026 results after the market closes on Wednesday, May 13th. Analysts expect Crescent Capital BDC to post earnings of $0.41 per share and revenue of $39.5750 million for the quarter. Interested persons are encouraged to explore the company's upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, May 14, 2026 at 12:00 PM ET.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.01. Crescent Capital BDC had a return on equity of 9.32% and a net margin of 20.64%.The firm had revenue of $19.05 million during the quarter, compared to analyst estimates of $39.83 million. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Stock Performance

CCAP stock opened at $13.92 on Wednesday. The stock has a 50-day moving average price of $12.96 and a 200-day moving average price of $13.82. Crescent Capital BDC has a 1-year low of $11.80 and a 1-year high of $17.02. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 1.24. The firm has a market cap of $514.62 million, a PE ratio of 14.81 and a beta of 0.59.

Crescent Capital BDC Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Tuesday, March 31st were given a $0.42 dividend. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.68 annualized dividend and a dividend yield of 12.1%. Crescent Capital BDC's dividend payout ratio (DPR) is 178.72%.

Institutional Trading of Crescent Capital BDC

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Ieq Capital LLC increased its position in Crescent Capital BDC by 3.0% in the 4th quarter. Ieq Capital LLC now owns 25,470 shares of the company's stock valued at $358,000 after buying an additional 746 shares in the last quarter. Mariner LLC increased its position in Crescent Capital BDC by 0.3% in the 4th quarter. Mariner LLC now owns 451,774 shares of the company's stock valued at $6,369,000 after buying an additional 1,492 shares in the last quarter. Northwestern Mutual Wealth Management Co. bought a new stake in Crescent Capital BDC in the 4th quarter valued at about $27,000. NewEdge Advisors LLC increased its position in Crescent Capital BDC by 20.2% in the 4th quarter. NewEdge Advisors LLC now owns 12,279 shares of the company's stock valued at $173,000 after buying an additional 2,066 shares in the last quarter. Finally, Royal Bank of Canada increased its position in Crescent Capital BDC by 3.6% in the 1st quarter. Royal Bank of Canada now owns 61,707 shares of the company's stock valued at $1,056,000 after buying an additional 2,128 shares in the last quarter. 49.46% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CCAP. Wall Street Zen raised Crescent Capital BDC from a "sell" rating to a "hold" rating in a research report on Saturday, January 10th. Keefe, Bruyette & Woods lowered their price objective on Crescent Capital BDC from $15.50 to $15.00 and set an "outperform" rating for the company in a research report on Thursday, April 16th. Zacks Research raised Crescent Capital BDC from a "strong sell" rating to a "hold" rating in a research report on Tuesday, February 10th. B. Riley Financial began coverage on Crescent Capital BDC in a research report on Monday, March 30th. They issued a "neutral" rating and a $13.50 price objective for the company. Finally, Wells Fargo & Company lowered their price objective on Crescent Capital BDC from $14.00 to $13.00 and set an "equal weight" rating for the company in a research report on Friday, February 27th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $15.50.

About Crescent Capital BDC

Crescent Capital BDC, Inc is a closed-end, externally managed business development company that provides flexible financing solutions to middle market companies in the United States. Trading on the Nasdaq under the ticker CCAP, the firm offers investors exposure to a diversified portfolio of debt and equity instruments, targeting businesses with attractive risk-adjusted return profiles. Its primary objective is to generate current income through interest payments and potential capital appreciation via selective equity co-investments.

The company’s investment strategy emphasizes senior secured loans, unsecured second-lien loans, mezzanine debt, as well as preferred and common equity co-investments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.